These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2429084)

  • 61. A common beta1-adrenergic receptor polymorphism (Arg389Gly) affects blood pressure response to beta-blockade.
    Sofowora GG; Dishy V; Muszkat M; Xie HG; Kim RB; Harris PA; Prasad HC; Byrne DW; Nair UB; Wood AJ; Stein CM
    Clin Pharmacol Ther; 2003 Apr; 73(4):366-71. PubMed ID: 12709726
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effects of beta-adrenoceptor agonists and antagonists on heart-rate variability in normal subjects assessed using summary statistics and nonlinear procedures.
    Silke B; Guy S; Riddell JG
    J Cardiovasc Pharmacol; 1997 Dec; 30(6):817-23. PubMed ID: 9436823
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Differential coupling to positive inotropic responses of cyclic AMP produced by stimulation of beta 1- and beta 2-adrenergic receptors.
    Yanagisawa T; Ishii K; Hashimoto H; Taira N
    J Cardiovasc Pharmacol; 1989 Jan; 13(1):64-75. PubMed ID: 2468937
    [TBL] [Abstract][Full Text] [Related]  

  • 64. β
    Cook RF; Bussey CT; Mellor KM; Cragg PA; Lamberts RR
    Exp Physiol; 2017 Aug; 102(8):911-923. PubMed ID: 28543947
    [TBL] [Abstract][Full Text] [Related]  

  • 65. An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.
    McCaffrey PM; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1987 Nov; 24(5):571-80. PubMed ID: 2893634
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Atenolol is inferior to metoprolol in improving left ventricular function and preventing ventricular remodeling in dogs with heart failure.
    Zacà V; Rastogi S; Mishra S; Wang M; Sharov VG; Gupta RC; Goldstein S; Sabbah HN
    Cardiology; 2009; 112(4):294-302. PubMed ID: 18832825
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical pharmacology of vasodilatory beta-blocking drugs.
    Shanks RG
    Am Heart J; 1991 Mar; 121(3 Pt 2):1006-11. PubMed ID: 1671724
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Does beta 1-selective agonistic activity interfere with the antihypertensive efficacy of beta 1-selective blocking agents?
    Leonetti G; Sampieri L; Cuspidi C; Terzoli L; Rupoli L; Fruscio M; Gradnik R; Zanchetti A
    J Hypertens Suppl; 1985 Dec; 3(3):S243-5. PubMed ID: 2908819
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Celiprolol and atenolol in angina--effects on left ventricular function.
    Dargie H; McLenachan JM; Wilson JT
    J Int Med Res; 1988; 16 Suppl 1():47A-51A. PubMed ID: 2906017
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Functional characterization of beta-adrenoceptor subtypes in rabbit right atria.
    Tenner TE; Young JA; Earley KJ; Yen YC
    Life Sci; 1989; 44(10):651-60. PubMed ID: 2564611
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Human pharmacokinetic and pharmacodynamic studies on Ro31-1118, a new beta-adrenoceptor antagonist.
    O'Connor PC; Arnold JM; Brown AN; Francis RJ; Finch MB; Galloway DB; Harron DW; McDevitt DG; Shanks RG
    Br J Clin Pharmacol; 1985 Mar; 19(3):319-27. PubMed ID: 2859047
    [TBL] [Abstract][Full Text] [Related]  

  • 72. An investigation into the type of beta-adrenoceptor mediating sympathetically activated renin release in the cat.
    Johns EJ
    Br J Pharmacol; 1981 Jul; 73(3):749-54. PubMed ID: 6113867
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evidence for cardiac beta 2-adrenoceptors in man.
    Brown JE; McLeod AA; Shand DG
    Clin Pharmacol Ther; 1983 Apr; 33(4):424-8. PubMed ID: 6299641
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Haemodynamic effects of atenolol and bopindolol at rest and during isometric exercise. A non-invasive study in healthy volunteers.
    Nieminen MS; Rapola J; Pellinen TJ; Toivonen L
    Ann Clin Res; 1988; 20(6):431-5. PubMed ID: 2905879
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Bioequivalence of two atenolol formulations in healthy volunteers. Evaluation and prediction of effect kinetics at beta-adrenoceptors in vivo by means of a radioreceptor assay.
    Sitzler G; Heibel B; Lücker PW; Palm D
    Methods Find Exp Clin Pharmacol; 1991 Mar; 13(2):129-37. PubMed ID: 1677061
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Acute effects of alcohol, beta blockade, and their combination on left ventricular function and hemodynamics in normal man.
    Kupari M; Heikkilä J; Tolppanen EM; Nieminen MS; Ylikahri R
    Eur Heart J; 1983 Jul; 4(7):463-71. PubMed ID: 6628423
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pilot study to assess the influence of beta-blockade on mitral regurgitant volume and left ventricular work in degenerative mitral valve disease.
    Stewart RA; Raffel OC; Kerr AJ; Gabriel R; Zeng I; Young AA; Cowan BR
    Circulation; 2008 Sep; 118(10):1041-6. PubMed ID: 18725484
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A prospective study of the effects of prolonged timolol therapy on alpha- and beta-adrenoceptor and angiotensin II receptor mediated responses in normal subjects.
    Ferro A; Hall JA; Dickerson JE; Brown MJ
    Br J Clin Pharmacol; 1997 Mar; 43(3):301-8. PubMed ID: 9088585
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Noninvasive assessment of left ventricular performance after administration of bisoprolol.
    Esper RJ; Esper RC; Burrieza OH; Menna J
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S87-91. PubMed ID: 2439806
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Intrinsic sympathomimetic activity of cardioselective beta-adrenoceptor blockers and effects on renal function.
    Mackay IG; Macnicol AM; Smith HJ; Cumming AD; Watson ML
    Br J Clin Pharmacol; 1985 Sep; 20(3):197-203. PubMed ID: 2864052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.